@coherentcmi.bsky.socialBispecific Antibodies Market: Growth, Trends, and Future Opportunities
Explore the full report from Coherent Market Insights:
www.coherentcmi.com/market-insig...
#BispecificAntibodiesMarket #BispecificAntibodies #Biopharmaceuticals #Immunotherapy #CancerResearch
@antibodytx.bsky.socialAntibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Review Highlight -Structure and function of therapeutic antibodies approved by the US FDA in 2024.
doi.org/10.1093/abt/... #biologics #bispecific #bispecificantibodies #bsab #bsabs #FDA
@antibodytx.bsky.socialAntibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Research Highlight - GB12-09, a bispecific antibody targeting IL4Rα and IL31Rα for atopic dermatitis therapy.
doi.org/10.1093/abt/...
#bispecificantibodies #bsab #bsabs #atopicdermatitis #th2cytokines #il4rα #il31rα
@gmj-georgia.bsky.socialA phase 2 trial of teclistamab-based induction therapy in newly diagnosed multiple myeloma has been published in Nature Medicine with an aut… #Bispecificantibodies #Clinicaltrial #Immunotherapy #Multiplemyeloma #Teclistamab #Bispecificantibodies #Clinicaltrial #Immunotherapy #Multiplemyeloma #T…
@gmj-georgia.bsky.socialNew phase 2 trial data: Teclistamab-based induction therapy achieves deep remissions in transplant-eligible newly diagnosed multiple myeloma… #BCMA #Bispecificantibodies #Cancerimmunotherapy #Clinicaltrials #Haematology #BCMA #Bispecificantibodies #Cancerimmunotherapy #Clinicaltrials #Haematolo…
@gmj-georgia.bsky.socialNew phase 2 trial data: Teclistamab-based induction therapy achieves deep remissions in transplant-eligible newly diagnosed multiple myeloma… #BCMA #Bispecificantibodies #Cancerimmunotherapy #Clinicaltrials #Haematology #BCMA #Bispecificantibodies #Cancerimmunotherapy #Clinicaltrials #Haematolo…